Product Information
BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Hospira Inc., priced at $26.4480 per EA under NDC 00409033220. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Mar 10, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
15 [USP'U]/1
Manufacturer
Hospira Inc.NDC
00409033220
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Effective Date
4/22/2026
Active Ingredients
BLEOMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA065031FDA Approved
3/10/2000
TE Code
AP
On Market Since
4/25/2015
Pharmacological Classes
Price Statistics
The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 94 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.4480 per EA |
|---|---|
| All-time high | $31.7820 (Dec 10, 2025) |
| All-time low | $24.0040 (Dec 17, 2025) |
| 52-week high | $31.7820 |
| 52-week low | $24.0040 |
| Median price | $31.7820 |
| Average price | $29.0304 |
| Largest weekly change | -24.5% (Dec 17, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BLEOMYCIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytoprotective Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Hospira Inc., is $26.4480 per EA (NDC 00409033220), effective Sep 30, 2026.
How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?
Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?
Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.
Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BLEOMYCIN SULFATE 15 UNIT VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?
BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 00409033220) is labeled by Hospira Inc., and CMS classifies it as a generic product.